MeMed For Profit
The immune system is built to communicate. Our mission is to listen. We apply machine learning to translate the complex signaling of the immune system into simple, actionable diagnostic insights. MeMed’s machine learning-based diagnostics address key clinical and medical challenges in infectious diseases and inflammatory disorders. MeMed BV Bacterial and viral infections are often clinically indistinguishable
Investors
Connections from
Founded Date:
2009-01-01
Investor Type:
N/A
Employee Number:
101-250
Investment Stage:
N/A
Funding Status:
Late Stage Venture
Number Of Exists:
N/A
Technology:
Biomarker panels
Industry:
Clinical Data Management
Headquarters:
Tirat Carmel, Hefa, Israel
Estimated Revenue:
$26 Million